Yarrow Bioscience YARW
NASDAQ YARW
$20.17 -0.04 (-0.20%)
At close: Oct 21, 2026 · 4:00 PM EDT

Yarrow Bioscience (YARW) Debt Ratio (2019 - 2021)

Updated

Yarrow Bioscience's Debt Ratio came in at 0.25 for Q2 2021, down 1.0% from 0.25 a year earlier but up 11.7% from the prior quarter.

Analysis

Yarrow Bioscience (YARW) Debt Ratio (2019 - 2021) Analysis & Trends

For FY2020, Yarrow Bioscience's Debt Ratio was 0.35, down 12.2% from FY2019.

  • Going back by year, Debt Ratio was 0.40 in FY2019.
  • The five-year range for quarterly Debt Ratio is 0.20 (Q1 2020) to 0.40 (Q4 2019).
  • Business Quant data shows YARW's Debt Ratio at 0.22 (Q1 2021), 0.35 (Q4 2020) and 0.31 (Q3 2020) in the three quarters before Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 0.39
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 0.24
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 0.52
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 0.42
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 0.08
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 0.28
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 0.60
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 0.53
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 0.31
10 Yarrow Bioscience 17.07 Mn -99.44 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 0.25
Mar 31, 2021 0.22
Dec 31, 2020 0.35
Sep 30, 2020 0.31
Jun 30, 2020 0.25
Mar 31, 2020 0.20
Dec 31, 2019 0.40
API Access

Yarrow Bioscience Debt Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=debt-ratio&ticker=YARW&period=max&api_key=YOUR_API_KEY